Clinical Trial Update: Exploring Unconventional Plant-Derived Metabolites for Glycemic Control: the Case of Pomegranate [NA]

View source ↗

Summary

A completed clinical trial evaluating pomegranate-derived metabolites for glycemic control in individuals with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Pomegranate (Punica granatum extract)

Snippet

Sponsor: Regina Menezes | Conditions: Prediabetes | NA | Status: COMPLETED